Amanda Davis
Adult Health · Ottumwa, IANPI 1861136897
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,740 of the $2,466 with a category attached, or 70.6%. 21 manufacturers reported payments, led by Medtronic at 33.0% of the total. 2025 is the largest year on record at $954, 2.6 times the $371 reported in 2022. Among adult health clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $27.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$815
- Astellas Pharma US Inc$669
- Pfizer$200
- Tolmar, Inc.$117
- 180 Medical, Inc.$103
- Sumitomo Pharma America, Inc.$101
- plus $461 from 15 others
What the payments were for
- Travel & lodging$2098%
- Food & beverage$1,74071%
- Education$51721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 18 | $815 |
| Astellas Pharma US Inc | 21 | $669 |
| Pfizer | 10 | $200 |
| Tolmar, Inc. | 6 | $117 |
| 180 Medical, Inc. | 4 | $103 |
| Sumitomo Pharma America, Inc. | 7 | $101 |
| Axonics, Inc. | 4 | $85 |
| Urovant Sciences Inc | 4 | $55 |
| Teleflex LLC | 3 | $50 |
| Procept Biorobotics Corporation | 2 | $39 |
| Johnson & Johnson | 2 | $38 |
| Organogenesis Inc. | 1 | $27 |
| UCB, Inc. | 1 | $24 |
| Bayer | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Tolmar Pharmaceuticals, Inc. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Photocure Inc | 1 | $15 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$425
How this compares
$2,466 in reported general payments places this provider in the 90th percentile of 77 adult health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 19 | $284,053 |
| GemtesaVibegron | 132 | $76,114 |
| MyrbetriqMirabegron | 63 | $35,838 |
| PremarinEstrogens, Conjugated | 23 | $9,894 |
| Estradiol | 100 | $6,451 |
| Methenamine Hippurate | 122 | $5,029 |
| Tamsulosin Hcl | 265 | $2,725 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $2,153 |
| Bethanechol Chloride | 55 | $1,273 |
| Finasteride | 107 | $718 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 25 | $525 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 40 | $471 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 23 | $293 |
| Ciprofloxacin Hcl | 44 | $251 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $146 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $669 | $319,89182 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $101 | $76,114132 claims |
| PfizerPremarin | $200 | $9,89423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 77 adult health providers in Iowa.
Other adult health in Ottumwa
- Megan GriffinOttumwa$86
- Kelsee BrowningOttumwa$57
- Lisa MeyerSioux City$8K
- Katie ShannonMason City$8K
- Barbara PetersonCedar Rapids$7K
- Eileen YeisleyIowa City$3K
- Suzanne HenningsIowa City$3K
- Jennifer BeckerIowa City$3K
- Breanna TalbertCedar Rapids$2K
- Julie ShawWest Des Moines$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.